ALAMEDA, Calif.--(BUSINESS WIRE)--Clue Genetics Inc. (Clue) is pleased to announce the appointment of Dr. Peter P. Repetti as its Vice President of Research. He will oversee development of Clue’s foundational platform of intellectual property centered on fungal genomes and will lead the company’s research initiatives in metabologenomics.
Dr. Repetti is an expert in molecular biology and microbial interactions and has a wealth of experience in the genomics arena, having previously held R&D leadership positions at Mendel Biotechnology, Koch Biological Solutions and BASF. “It’s an exciting time to be working with fungal genomes, as the Earth’s most under-appreciated kingdom of life finally is in the spotlight. Clue’s extensive library of organisms represents a unique resource for new discovery across sectors including drug discovery, small molecule natural products, and novel enzymes,” noted Dr. Repetti. “Fungi are the way of the future and I’m excited to be part of it!” Dr. Cedric Pearce, President of Clue added, “We’re delighted to have Peter join the Clue team–his extensive experience in genomics makes him ideally suited to lead the build-out of the company’s technology platform.”
Dr. Repetti will assume this new position on July 1, 2022. He will be based at Clue’s laboratory facility near RTP, North Carolina.
About Clue Genetics: Clue is a fungal genomics company that was founded with the vision to be the leading technology platform for delivering natural product solutions to a broad range of industries. For more information visit: https://cluegen.com/
